Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy.

Yasuyuki TamaiMotoh IwasaAkiko EguchiRyuta ShigefukuYoshihiro KamadaEiji MiyoshiYoshiyuki Takei

Published in: JGH open : an open access journal of gastroenterology and hepatology (2021)

Rifaximin (RFX) treatment can attenuate not only hyperammonemia but also Enterococcus faecalis translocation and 10-7G values, suggesting that RFX treatment may improve intestinal inflammation and result in better overall survival.

Keyphrases

oxidative stress
mouse model
free survival
smoking cessation